Title:

"Willingness to pay for a Quality Adjusted Life Year of stage IIIb/IV non-small cell lung cancer patient”.

Time:

From 20th July to 15th October, 2018,

Venue:

The Center for Population Health Sciences, Hanoi University of Public Health.

General objectives:

Provide scientific evidence to health policy makers and health insurance providers to evaluate the payment ability of patients with stage IIIb/IV non-small cell lung cancer.

Specific objectives:

  • To estimate willingness to pay (WTP) for a Quality Adjusted Life Year of stage IIIb / IV non-small cell lung cancer patients in some hospitals in Vietnam in 2018.
  • To analyze factors related to willingness to pay for a Quality Adjusted Life Year among study subjects.

Research sites:

The study was conducted in a number of central and city hospitals eligible for stage IIIb / IV non-small cell lung cancer treatment in Hanoi, Da Nang and Ho Chi Minh City:

  • Bach Mai Hospital - The Nuclear Medicine and Oncology center.
  • National Cancer Hospital
  • Hanoi Oncology Hospital
  • Da Nang Oncology Hospital
  • HCMC Medical and Pharmacy University Hospital.

Methodology:

Cross-sectional study. Quantitative survey.

Implementing agency:

Center for Population Health Sciences (CPHS) - Hanoi University of Public Health.

Co – implementing agencies:

  • Department of Health Insurance - Ministry of Health
  • Vietnam Health Economics Association
  • Bach Mai Hospital
  • National Cancer Hospital
  • Hanoi Oncology Hospital
  • Da Nang Oncology Hospital
  • HCMC Medical and Pharmacy University Hospital

 

Funding agency:

AstraZeneca Vietnam.

Chủ đề :